Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | Novo Nordisk A/S (NOVO.B.CO) | 2019-12-31 | 3 years ago | DKK | 431.95 | 94.09 | 21.78% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 102 | Coloplast A/S (COLO B.CO) | XCSE | DK | 2023-09-30 | 12 hours ago | DKK | 906.00 | 196.60 | 21.70% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 103 | ALK-Abello A/S (ALK B.CO) | XCSE | DK | 2023-12-31 | 12 hours ago | DKK | 125.60 | 26.62 | 21.19% | 3.11 | 2.48% | NCAV (Net-Net) | 3.11 | 2.48% |
| 104 | Ambu A/S (AMBU B.CO) | XCSE | DK | 2023-09-30 | 12 hours ago | DKK | 109.30 | 17.38 | 15.91% | 2.04 | 1.86% | NCAV (Net-Net) | 2.04 | 1.86% |
| 105 | Torm PLC (TRMD.A.CO) | 2019-12-31 | 3 years ago | DKK | 43.60 | 5.88 | 13.48% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 106 | Genmab A/S (GMAB.CO) | XCSE | DK | 2023-12-31 | 12 hours ago | DKK | 2,006.00 | 265.60 | 13.24% | 45.33 | 2.26% | NCAV (Net-Net) | 45.33 | 2.26% |
| 107 | Coloplast A/S (COLO.B.CO) | 2019-09-30 | 3 years ago | DKK | 926.60 | 116.91 | 12.62% | 2.54 | 0.27% | NCAV (Net-Net) | 2.54 | 0.27% | ||
| 108 | Novo Nordisk A/S (NOVO B.CO) | XCSE | DK | 2023-12-31 | 12 hours ago | DKK | 866.20 | 85.91 | 9.92% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 109 | Cbrain A/S (CBRAIN.CO) | XCSE | DK | 2023-12-31 | 12 hours ago | DKK | 306.50 | 24.38 | 7.95% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 110 | Ambu A/S (AMBU.B.CO) | 2019-09-30 | 3 years ago | DKK | 246.10 | 17.19 | 6.98% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |